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Polymorphonuclear neutrophils (PMNs) are involved in host defence against infections by the pro-
duction of reactive oxygen species (ROS), but excessive PMN stimulation is associated with the
development of inﬂammatory diseases. After appropriate stimuli, protein kinase C (PKC) triggers
the assembly of NADPH oxidase (Nox2) which produces superoxide anion (O2 ), from which ROS
derive. The therapeutic use of polyphenols is proposed to lower ROS production by limiting Nox2
and PKC activities. The purpose of this study was to compare the antioxidant effect of NDS27 and
NDS28, two water-soluble forms of curcumin lysinate respectively complexed with hydroxypro-
pyl-b-cyclodextrin (HPbCD) and c-cyclodextrin (c-CD), on the activity of Nox2 and PKCd, involved
in the Nox2 activation pathway. Our results, showed that NDS27 is the best inhibitor for Nox2 and
PKCd. This was illustrated by the combined effect of HPbCD and curcumin lysinate: HPbCD, but
not c-CD, improved the release of curcumin lysinate and its exchange against lipid or cholesterol
as demonstrated by the lipid colouration with Oil Red O, the extraction of radical lipophilic probes
recorded by ESR and the HPLC measurements of curcumin. HPbCD not only solubilised and trans-
ported curcumin, but also indirectly enhanced its action on both PKC and Nox2 activities. The mod-
ulatory effect of NDS27 on the Nox2 activation pathway of neutrophils may open therapeutic
perspectives for the control of pathologies with excessive inﬂammatory reactions.
 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).1. Introduction
For the destruction of pathogenic agents during phagocytosis,
polymorphonuclear neutrophils (PMNs) increase their molecular
oxygen consumption, a process known as the ‘‘oxidative burst’’,
to produce reactive oxygen species (ROS) [1]. During this oxidative
burst, NADPH oxidase, or Nox2, a multi-component key enzyme,
produces superoxide anion O2 , the ﬁrst specie from which most
of the other ROS derive. In resting cells, subunits of NADPH oxidase
are spread between membrane and cytosol. Upon stimulation ofappropriate receptor, such as C5a or formyl-methionyl-leucyl-
phenylalanine (fMLP) receptor, translocation of the cytosolic
Nox2 components p40phox, p47phox and p67phox to the
membrane-bound ﬂavocytochrome b558 (comprising gp91phox
and p22phox) is induced [2]. This translocation requires, not only
a conformational modiﬁcation and phosphorylation of the Nox2
components, but also a complex set of protein/protein interactions
[3]. The protein kinase C (PKC) family appears to play a major role
in this process especially upon stimulation of PMNs by phorbol
12-myristate 13-acetate (PMA) or fMLP [2].
Neutrophils express PKCa, b and d that can all initiate the
superoxide generation in cell-free systems. PKCd is required after
fMLP stimulation and needs phosphatidylserine and diacylglycerol
but is Ca2+ independent unlike other PKC family members [4]. PKCs
d are primarily localised in the cytosol of unstimulated neutrophils.
In response to agonist stimulation, a fraction of PKCs d rapidly
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required to activate NADPH oxidase by phosphorylation of its
cytosolic and membrane subunits, especially p47phox [5,6].
The oxidant activity of neutrophils is required for their normal
microbicidal function but their excessive stimulation, as found in
inﬂammation situations, leads to the extracellular release of ROS
and oxidant enzymes such as myeloperoxidase (MPO), causing
deleterious effects on neighbouring cells and tissues [7]. As in
humans, uncontrolled activation of PMNs in the horse can be
related to irreversible endotoxic shock [8–10]. A therapeutic goal
could be to lower the oxidant activity of excessively stimulated
neutrophils by modulating the activity of MPO [11] or NADPH
oxidase, both responsible for ROS production. To this end, NADPH
oxidase appears as the prime target since it produces the ﬁrst ROS
from which the others are derived [12].
With this objective in mind, we were interested in the study of
curcumin, a natural phenolic compound of turmeric (Curcuma
longa), widely used as a food dye and ﬂavouring [13]. Curcumin
was reported to inhibit the activation of leukocytes, including
PMNs [11,14] and monocytes [15], and to have numerous other
properties [13,14,16–18]. This wide range of biological activities,
associated with a low toxicity justiﬁes the therapeutic interest in
using curcumin [14,19]. The action of curcumin involves interac-
tions with transcription factors, cytokines and enzymes [16,20]
and inhibition of the oxidative response by activated PMNs
through the inhibition of ROS generation and scavenging [14,21].
Curcumin can also interfere with the MPO activity [11], a major
contributor to ROS production in neutrophils. However, as the
insolubility of curcumin in aqueous milieu makes its use very difﬁ-
cult in biochemical assays, we developed two highly water-soluble
salts of curcuminoid derivative, NDS27 and NDS28, complexed
with hydroxypropyl-b-cyclodextrin (HPbCD) and c-cyclodextrin
(c-CD) respectively [22]. We previously demonstrated the capacity
of curcumin to inhibit the oxidative burst of neutrophil through
the inhibition of MPO [11] and NADPH oxidase [23] activities.
Furthermore, we have also shown that, this capacity appeared to
be improved in the soluble form of curcumin lysinate via its ability
to interact with membranes and to enter the cells [24]. We thus
hypothesised that the cyclodextrin from NDS27, HPbCD, enhances
the action of curcumin against the oxidative burst. The purpose of
the present work was to determine and compare the effect of the
complexes of curcumin lysinate with two different types of
cyclodextrins (HPbCD and c-CD) on the activity of NADPH oxidase
and PKCd situated just upstream in the PMN activation pathway.2. Materials and methods
2.1. Chemicals and reagents
Analytical grade Na, K, Ca, Mg salts, polyvinylidene diﬂuoride
(PVDF) membrane and Tween 20 were from Merck. Phenylmethyl-
sulfonyl ﬂuoride (PMSF), leupeptin, pepstatin, guanosine
50-[c-thio] triphosphate tetralithium salt (GTP-c-S), sodium ara-
chidonate, cytochrome C from horse heart, nicotinamide adenine
dinucleotide phosphate reduced (NADPH), superoxide dismutase
from bovine erythrocyte (SOD), cytochalasin B, N-formyl-methio-
nyl-leucyl-alanine (fMLP), Oil Red O, ethylene glycol-bis(2-amino-
ethylether)-N,N,N0,N0-tetraacetic acid (EGTA), Na-tosyl-L-lysine
chloromethyl ketone hydrochloride, HEPES, 5-doxyl stearic acid
(2-(3-carboxypropyl)-4,4-dimethyl-2-tridecyl-3-oxazolidinyloxy,
free radical) and 16-doxyl stearic acid (2-(14-carboxytetradecyl)-
2-ethyl-4,4-dimethyl-3-oxazolidinyloxy, free radical) were pur-
chased from Sigma–Aldrich (Bornem, Belgium). Nitrotetrazolium
blue chloride (NBT) and 5-bromo-4-chloro-3-indolyl phosphate
disodium salt (BCIP) were both from Fermentas (Sankt Leon-Rot,Germany) and IMDMmedium, penicillin, streptomycin, amphoter-
icin B, fetal bovine serum and Hanks’ balanced salt solution (HBSS)
were from Gibco-Invitrogen (Fischer Scientiﬁc, Erembodegem, Bel-
gium). Isopropanol was purchased from VWR (Leuven, Belgium).
Bovine serum albumin (BSA) was from Roche (Mannheim,
Germany). NDS27, NDS28, HPbCD and c-CD were gifts from
Philippe Neven (Faculty of Pharmacy, University of Liège, Belgium).
All concentrations of NDS27 and NDS28 were expressed in term of
molar concentration of pure curcumin and contain a 5-fold
increased concentration in HPbCD and c-CD respectively.
2.2. Methods
2.2.1. Animals experiments
All the experiments were realised in accordance with the ethic
committee of the Faculty of Veterinary Medicine of University of
Liege (agreement number 1474). Equine neutrophils were isolated
from whole blood drawn on citrate–phosphate–dextrose (PL146,
Baxter Healthcare) or EDTA (Vacuette, Greiner Bio-one) from the
jugular vein of healthy horses, fed and bred in identical conditions
and not under medical treatment (Faculty of Veterinary Medicine,
University of Liège, Belgium). Horses were considered as healthy if
no clinical signs of acute disease were observed at the time of sam-
pling. Each batch of neutrophils was obtained from blood drawn
from one horse. Samples were collected by a qualiﬁed veterinarian
from the equine clinic of University of Liège in aseptic conditions
without any surgery, anaesthetic procedure or risk for the animal.
2.2.2. Cell culture
Human promyelocytic leukemia cells (HL-60) were obtained
from the American Type Culture Collection (ACCT, USA) and cul-
tured in IMDM medium supplemented with 20% (v/v) fetal bovine
serum, 100 units/ml penicillin/streptomycin, 1.25 mg/ml ampho-
tericin B, and 2 g/l NaHCO3 in 50 ml ﬂasks at 37 C in a 5% CO2
humidiﬁed atmosphere. Cells were supplied with fresh medium
two to three times per week to maintain log phase growth. Once
a week, the contents of culture ﬂasks were centrifuged and the cell
pellets resuspended in fresh IMDM and divided into new culture
ﬂasks. Before each experiment, cells were counted with Burker’s
cell (Briare, France) to reach the cell number required for the
experiments.
2.2.3. Detection of phosphorylated PKC by Western blot
Equine neutrophils (20  106 cells) isolated as previously
described [24], were resuspended in 1 ml HBSS with 104 M
NDS27 or NDS28 or 5  104 M HPbCD or c-CD. A control with
HBSS alone was realised. After 30 min incubation with the appro-
priate treatment at 37 C, cells were activated with cytochalasin
B (CB, 5 lM) for 15 min followed by another 15 min incubation
with 108 M fMLP. The suspensions were centrifuged (10 min,
450g) to remove NDS27, NDS28, HPbCD or c-CD and cells were
resuspended in 3 ml of Buffer A (HEPES 10 mM, KCl 100 mM, NaCl
10 mM, MgCl2 3.5 mM, EGTA 12 mM, pH 7.3) [25] supplemented
with a protease inhibitor cocktail (N-a-p-tosyl-L-lysine chloro-
methyl ketone 10 mM, PMSF 1 mM, leupeptin 1.8 lM, pepstatin
1.5 lM). Thereafter cells were sonicated (6  5 s, 30% amplitude,
Labsonic P, Sartorius) and ultracentrifuged (1 h, 165,000g, 4 C).
The supernatant, corresponding to cytosolic proteins, and the
pellet containing membrane proteins resuspended in 500 ll of
Buffer A supplemented with anti-proteases cocktail, were kept
for further western blotting analysis.
Protein samples (5–10 lg in a total volume of 10 ll Buffer A)
were added with 4 ll of loading buffer (Nu PAGE LDS sample
buffer, Invitrogen) and 1.6 ll of reducing agent (Nu PAGE sample
reducing agent, Invitrogen). Samples were denatured 10 min at
70 C and 15 ll were loaded on a 4–12% Bis–Tris gel (Nu PAGE,
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Running Buffer (Invitrogen), the proteins were transferred to a
PVDF membrane using a semi-dry electroblotter (55 min, 15 V)
and then blocked 30 min in Tris-buffered saline (TBS) containing
Tween 20 (0.1%) and BSA (1%). After washing with TBST
(TBS + 0.1% Tween 20), the membranes were incubated for 1 h with
p-PKC d rabbit polyclonal IgG (Santa Cruz Biotechnology, pPKCd ser
645-R, sc18369-R, dilution: 200), washed once with TBST, then
incubated for 30 min with anti-rabbit IgG antibodies from goat
conjugated to alkaline phosphatase (Abcam, ab97048, dilution:
3000). After three washing steps of 5 min each with TBST and
another one with TBS, the staining was achieved by using Nitro
blue tetrazolium (NBT) and 5-Bromo-4-chloro-3-indolyl phosphate
(BCIP) as substrate for alkaline phosphatase. To quantify the blot,
imageJ software [26] was used. The relative values were reported
by mg of proteins and the ratio between p-PKCd found in
membrane and in the cytosol was calculated to evaluate the part
of PKCd that migrated to the membrane.
2.2.4. IC50 determination of NDS27 and NDS28 on PKCd activity
A radiometric protein kinase assay (33PanQuinase Activity
assay) made by ProQinase (Freiburg, Germany) was used for mea-
suring the kinase activity of the PKCd protein kinase. The kinase
assay was performed in 96-well FlashPlates from PerkinElmer
(Boston, MA, USA) in a 50 ll reaction volume. The reaction cocktail
was prepared in the following order: 20 ll of assay buffer (or stan-
dard buffer), 5 ll of ATP solution (in H2O), 5 ll of tested compound
(NDS27 and NDS28 from 104 M to 3  109 M; HPbCD and c-DC
from 5  104 to 1.5  108 M in 10% DMSO) and 20 ll enzyme/
substrate mix. The assay mixture contained 70 mM HEPES–NaOH,
pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 lM Na-orthovanadate,
1.2 mM DTT, 50 lg/ml PEG20000, 10 lM ATP, [c-33P]-ATP (approxi-
matively 6  105 cpm per well), 4.5 nM recombinant PKCd
(ProQinase), 0.125 lg/50 ll substrate (PKC 19–31).
The reaction cocktails were incubated at 30 C for 60 min. The
reaction was stopped with 50 ll of 2% (v/v) H3PO4 and the plates
were washed two times with 200 ll of 0.9% (w/v) NaCl. Incorpora-
tion of 33Pi was determined with a microplate scintillation counter
(Microbeta, Wallac). All assays were performed with a Beckman
Coulter/SAGIAN core system.
The median value of the counts obtained in absence of a protein
kinase but in presence of the substrate was deﬁned as ‘‘low con-
trol’’ and represented the unspeciﬁc binding of radioactivity to
the plate. The median value of the counts for the protein kinase
fully active without inhibitor was taken as the ‘‘high control’’.
The difference between high and low control was taken as 100%
activity. The residual activity for each tested compound was
calculated with the following formula:
Residual Activityð%Þ ¼ 100 ½ðcpm of compound
 low controlÞ=ðhigh control
 low controlÞ
The residual activities for each concentration and the
compound IC50 values were calculated using Quattro Workﬂow
V3.1.0 software (Quattro Research GmbH, Munich, Germany,
www.quattro-research.com). The ﬁtting model for IC50 determina-
tions was ‘‘Sigmoidal response (variable slope)’’ with parameters
‘‘top’’ ﬁxed at 100% and ‘‘bottom’’ at 0%. The ﬁtting method used
was a least-square ﬁt.
2.2.5. Cell-free system of oxidase activation
As previously described [23], 2 lg of crude membranes and
50 lg of cytosolic proteins were stimulated by addition of 10 ll
sodium arachidonate and 2 ll of guanosine 50-[c-thio]
triphosphate tetralithium salt (GTP-c-S) (2 lM). A preliminaryassay was performed with each batch to determine the optimal
amount of sodium arachidonate to be added to provide maximal
oxidase activation. The cell-free assay activation was performed
in 96-well plates (microtiter assembly breakable strip, Thermo
Fisher Scientiﬁc) in a total volume of 200 ll phosphate buffered
saline (PBS) plus 10 mM MgSO4. After 5 min incubation under stir-
ring (RT, 600 rpm), 30 ll cytochrome C (100 lM) were added.
Reduction of cytochrome C was initiated by the addition of 10 ll
NADPH (250 lM) and the increase of absorbance at 550 nm was
followed with a multi-plate reader (Multiskan Ascent FL, Thermo
Fisher Scientiﬁc) during 5 min. For each experiment, a control
supplemented with 200 U/ml superoxide dismutase (SOD), was
performed in parallel to the same test without SOD (replaced by
an equivalent volume of PBS + MgSO4). The difference of absorbance
between the reduction of cytochrome C in the presence and absence
of SOD was used to evaluate the speciﬁc reduction of cytochrome C
by O2  generated by the oxidase activity. The O2  concentration was
calculated using Beer–Lambert law with an absorption coefﬁcient of
cytochrome C equal to 21.1 mM1 cm1 at 550 nm.
In a ﬁrst experimental model, the tested molecules
(106–104 M NDS27 or NDS28 and 5  106 to 5  104 M HPbCD
or c-CD) were pre-incubated for 5 min at room temperature under
stirring before the assembly of NADPH oxidase by sodium
arachidonate and GTP-c-S. Then, cytochrome C, SOD (for controls)
or PBS + MgSO4 and NADPH were added to measure the oxidase
activity. In a second model, the tested molecules were added under
stirring (600 rpm) after the assembly with sodium arachidonate
and GTP-c-S and, after 5 min incubation, the NADPH oxidase
activity was measured as for the ﬁrst model.
2.2.6. Measurement of lipid content by Oil Red O
Five million PMNs/milliliter in HBSS were incubated with 103,
2  103 or 3  103 M NDS27 or NDS28 or with 5  103,
10  103 or 15  103 M HPbCD or c-CD for 2 h at 37 C. Cells
were then centrifuged (5 min, RT, 524g) and the supernatant
containing the excess of tested molecules, was discarded. The pel-
let was washed with 1 ml of HBSS. After the washing step, the cell
pellets were separated in two parts: in the ﬁrst one, 500 ll of Oil
Red O (1% w/v diluted in a mixture of isopropanol and water 3:2)
were added and in the second part, 500 ll of isopropanol/water
mixture (3:2) were added as control. After a 30-min period of incu-
bation at 37 C, cells were washed three times with 1 ml of HBSS
and resuspended in 500 ll of HBSS. 200 ll of each sample were
placed in the cavities of a microplate and the absorbance was
measured at 540 nm with a microplate reader (Multiskan Ascent
FL, Thermo Fisher Scientiﬁc). Absorbance values of the control tests
with isopropanol/water mixture were subtracted from absorbance
values of cells coloured by Oil Red O to avoid interferences due to
the natural colour of curcumin.
2.2.7. Electron spin resonance (ESR) experiments with 5- and 16-DSA
HL-60 cells (5  106/500 ll of HBSS) were incubated for 20 min
with 5 ll of either 5- or 16 DSA (0.01 M). The cells were then cen-
trifuged and the pellets were resuspended in 500 ll HBSS supple-
mented with either 104 M NDS27, NDS28, 5  104 M HPbCD or
c-CD and incubated for 10 min at RT. Subsequently, cells were
centrifuged and the pellet (resuspended in 500 ll of HBSS) and
supernatant were transferred into separate micro-caps tubes
(sealed with rubber and transferred into ESR tube), placed into
the cavity of the ESR spectrometer. The ESR characteristic spectra
of the 5-DSA and 16-DSA signals were recorded. The measure-
ments were implemented at 300 K with a continuous wave
spectrum EMX-micro of Bruker (Brüker, Rheinstetten, Germany),
operating at ﬁxed X-band frequency of 9.5 GHz and at a microwave
power of 10.88 mW. The instrumental settings were as follows:
100 kHz modulation frequency, 2 G modulation amplitude,
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sweep width was 89.652 G and the total number of scans was ﬁve.
2.2.8. HPLC quantiﬁcation of curcumin from NDS27 and NDS28
incorporated into the cells
HPLC quantiﬁcation of curcumin was performed as previously
described [24]. Brieﬂy, 100  106 isolated PMNs were resuspended
in 2 ml of PBS supplemented with NDS27 or NDS28 (104 M) and
incubated 30 min at 37 C. The cells were then washed and sepa-
rated into different fractions [24]. The assay of curcumin was per-
formed by a HPLC system including a Merck Hitachi L-7100 solvent
delivery system (pump) working at a ﬂow rate of 0.7 ml/min, a
Merck Hitachi L-7400 UV detector and a 7725i rheodyne injector
with a loop of 20 ll. The EZ Chrom ELITE software was used for
integration. Chromatography was conducted using a Merck Lichro-
Cart 125-4 LiChrospher 100 RP-18 (5 lm) column with an isocratic
elution with tetrahydrofuran (THF)/50 mM citrate buffer (pH = 6)
(66:34) and detection at 419 nm using a UV detector.
2.3. Statistical analysis
Data are given in relative values (%) in reference to control
groups deﬁned as 100%. All data are expressed as mean ± standard
error of the mean (S.E.M.) of at least two independent experiments
made with different cell batches. Statistical analysis was realised
with corresponding solvent vehicle control group as reference.
An independent t-test was performed with SOFA statistics 1.3.2
(Released under open source AGPL3 licence 2009–13 Paton-
Simpson & Associates Ltd.). A Mann–Whitney test was realised
for data that did not respect a Gaussian distribution. A p-value
<0.05 was considered as signiﬁcant.
3. Results
3.1. Effect of NDS27 and NDS28 on the phosphorylation and
translocation of PKCd
The Western blot analysis showed that, in activated PMNs (C),
the signal corresponding to p-PKCd was stronger in the fraction
containing the membranes compared to cytosolic fractions
(Fig. 1A). Upon pre-incubation of the cells with 104 M NDS27 or
with 5  104 M HPbCD, we observed a reduction of the p-PKCd
content in membranes but an increase in the cytosol suggesting
that NDS27 and HPbCD decreased the migration of phosphorylated
PKC to the membrane and thus the enzyme activation (Fig. 1A). The
quantiﬁcation and calculation of p-PKCd ratio between membrane
and cytosol extracts showed that NDS27 and HPbCD signiﬁcantly
reduced the PKCd activation (respectively 50% and 71%,
Fig. 1B). Incubation of PMNs with 104 M NDS28 or 5  104 M
c-CD slightly increased the p-PKCd content in membrane fractions
and reduced it in the cytosol (Fig. 1C), resulting in a non-signiﬁcant
increase of the membrane/cytosol ratio (Fig. 1D).
3.2. Effect of NDS27 and NDS28 on PKCd activity
The hill slopes characteristic of the curve shapes were calcu-
lated for each condition and a hill slope higher than 0.4 would
mean that the curve was not sigmoidal, very ﬂat or not descending.
As observed in Fig. 2A and C, the shape of the dose–response curves
with NDS27 and NDS28 were sigmoidal as conﬁrmed by the hill
slopes lower than 0.4 (1.37 and 1.23 respectively). The IC50
determined for the two molecules were quite similar:
1.67  105 M for NDS27 and 1.26  105 M for NDS28. For HPbCD
and c-CD the hill slopes were higher than 0.4 showing no
inhibition (Fig. 2B and D).3.3. Effect of NDS27 and NDS28 on the activity of NADPH oxidase
NDS27, NDS28, HPbCD or c-CD were added before or after
NADPH oxidase activation with GTP-c-S and sodium arachidonate.
NDS27 exhibited a dose-dependent inhibitory effect on the O2 
production and this effect was more pronounced when the mole-
cule was added before the enzyme assembly (Fig. 3A). The inert
vehicle substance, or excipient of NDS27, HPbCD, has a stronger
inhibitory effect when added alone than in combination with
curcumin salt (NDS27). Again, the effect of HPbCD was more
important when it was added before the NADPH oxidase
activation. NDS28 and c-CD added before the enzyme assembly
had no effect on the NADPH oxidase activity (Fig. 3B). When
c-CD was added after assembly, it showed a pro-oxidant activity
by increasing O2  production, however a signiﬁcant effect was only
observed at 25  105 M.
3.4. Inﬂuence of NDS27 and NDS28 on the lipid content of cell
membranes
Pre-incubation with NDS27 (2 and 3  103 M) resulted in a sig-
niﬁcant dose-dependent reduction in the lipid content of PMNs
(Fig. 4A). HPbCD alone showed the same signiﬁcant effect at the
ﬁnal corresponding concentration of 10  103 and 15  103 M
but the reduction of lipid content was less important than
observed with NDS27. In contrast, pre-incubation with both
NDS28 and c-CD did not affect the lipid content of the cells, except
at 2  103 M, where we observed an increase of Oil Red O colour-
ation (Fig. 4B).
3.5. Effect of NDS27 and NDS28 on 5-DSA and 16-DSA probe extraction
from cell membranes
The 5-DSA and 16-DSA probes are detected by ESR spectroscopy
based on their nitroxide radical located on 5th and 16th carbon,
respectively. They are characterised by different lengths of the
hydrophobic chain near the nitroxide radical allowing them to
anchor more (16-DSA) or less (5-DSA) deeply in the membrane.
The ESR spectra of both 5-DSA and 16-DSA probes, incubated with
HL-60 cells (control), were quite similar for the cellular pellet and
the supernatant, meaning that only a part of the probe is ﬁxed on
the cells after incubation (Figs. 5A and B and 6A and B). When the
cells pre-incubated with 104 M NDS27 or 5  104 M HPbCD,
increased ESR signal was observed for the supernatant (Fig. 5A,
dotted lines), which is characteristic of the ESR spectrum shape
of 5-DSA free in a buffer medium. The spectrum recorded on the
pellets showed weak signals compared to control pellets (Fig. 5A,
plain lines) suggesting that only a small part of the probe remained
in the cell membrane after NDS27 or HPbCD treatment. The quan-
tiﬁcation of the ESR signal intensity allowed us to establish the
tight relationship between the presence of the drug (e.g. NDS27)
within the cell membrane and the uptake of the probe (5-DSA) out-
side, thus increasing the signal intensity of free 5-DSA from 895%
for NDS27 vs. 778% in the presence of HPbCD (Fig. 5C). We also
obtained a reduction of the signal intensity for the cellular pellets:
28% for NDS27 and 30% for HPbCD (Fig. 5C). A similar effect was
observed when using the 16-DSA probe instead of the 5-DSA one.
Intense signals, characteristic of the free probe, observed in the
supernatant when cells were pre-incubated with NDS27 or HPbCD
(Fig. 5B) but the difference for both signals compared to the control
was less marked than with 5-DSA. The quantiﬁcation of signal
intensities showed an increase of 58% and 44% respectively in the
supernatant for NDS27 and HPbCD and a reduction of 74%
(NDS27) and 77% (HPbCD) in cellular pellets compared to control
(Fig. 5D). On the contrary, NDS28 and c-CD, exhibited little
Fig. 1. Detection of phosphorylated PKCd (p-PKCd) in cytosolic and membrane extracts from activated PMNs treated or not with NSD27, NSD28, HPbCD or c-CD. (A and C)
Example of western blotting. C: control cells; 27: cells treated with 104 M NDS27; H: cells treated with 5  104 M HPbCD; 28: cells treated with 104 M NDS28; G: cells
treated with 5  104 M c-CD. (B and D) Quantiﬁcation of pPKC detected in the cellular extracts (ImageJ software). For each condition, results are expressed as the ratio of p-
PKCd detected in membrane vs. cytosolic extracts. The percentage of inhibition indicated on the top of each column is calculated vs. the ratio obtained for control cells taken
as 100%. Control: control cells; NDS27: cells treated with 104 M NDS27; HPbCD: cells treated with 5  104 M HPbCD; NDS28 cells treated with 104 M NDS28; c-CD: cells
treated with 5  104 M c-CD. ⁄p < 0.05 vs. control. Data are given as means ± S.E.M. (nP 4).
Fig. 2. Effect of NDS27 (A), HPbCD (B), NDS28 (C) or c-CD (D) concentration (black lines) on the residual activities of PKCd (%). A horizontal light gray line shows the inﬂection
points of the curves corresponding to the IC50.
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membrane compared to control (Fig. 6).
3.6. Capacity of curcumin from NDS27 and NDS28 to enter the cells
We previously published that the supernatant and the wash
fractions of PMNs incubated with NDS27 contained 31.80% and
3.19% of total curcumin respectively. After sonication and two
centrifugation steps, 2.48% of curcumin was found in the cytosol,
16.49% in the membrane and 45.65% in the cellular debris,
consisting of granules, nuclei and unbroken cells. The total relative
amount of curcumin entering the PMNs was estimated to be64.62% [24]. Our HPLC measurement also demonstrated that most
of the curcumin from NDS28 did not enter PMNs incubated with
this molecule as 84.22% of curcumin remained in the supernatant
and 1.17% was recovered after the two washing steps. After
sonication and two centrifugation steps, 1.78% of curcumin was
found in the cytosol fraction, 2.63% in the membranes and
10.07% in the cellular debris (Fig. 7).
4. Discussion
Our present ﬁndings [11] and those previously described by
other groups including Nakamura et al. [27] have successfully
Fig. 3. Effect of NDS27 and HPbCD (A) or NDS28 and c-CD (B) on NADPH oxidase assembly and activity as determined by O2 production in cell-free assay. The tested
molecules were added before (dark gray) or after (light gray) NADPH oxidase assembly. The percentages of inhibition indicated on the top of each column were calculated vs.
the respective control group (CM), ⁄⁄p < 0.001, ⁄p < 0.05. CM: reconstituted complex without the tested molecule. Data are given as means ± S.E.M (nP 6).
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iated by stimulated neutrophils. More recently, our group brought
further evidence that curcumin acts not only by a ROS-scavenging
effect, but also by inhibiting the NADPH oxidase activity in cell-free
assay [23]. However, the lack of curcumin solubility in aqueous
medium combined with a poor intestinal absorption [28] may
reduce its potential therapeutic effects and complicate its use for
biochemical assays. For these reasons, our team has synthesised
NDS27 and NDS28, two water-soluble complexes of curcumin
lysinate prepared with two different cyclodextrins: 2-hydroxypropyl-
beta-cyclodextrin (HPbCD) and c-cyclodextrin (c-CD), respectively.
As for curcumin, both NDS27 [24] and NDS28 (unpublished results)
presented great efﬁciency in inhibiting ROS production from activated
PMNs and also led to a reduction of the activity of MPO, a strong
oxidant enzyme of PMNs. However, their effects on NADPH oxidase
activity, more and more considered as a target to modulate inﬂamma-
tory events [12], had not yet been investigated.
In this study, we demonstrate that NDS27 behaves as a potent
inhibitor of NADPH oxidase in cell-free system. The inhibitory
effect was more efﬁcient when NDS27 was added before
(signiﬁcant inhibition from 105 M) than after the enzyme
assembly (signiﬁcant inhibition at 104 M), suggesting that
NDS27 acts by inhibiting the enzyme assembly rather than by
acting on its activity. These ﬁndings are in accordance with our
previous results obtained with pure curcumin [23], but
NDS27exhibited greater inhibitory effect than the parent
compound curcumin to reduce NADPH oxidase assembly since at
104 and 5  105 M, it totally inhibited the enzyme activity in
cell-free assay while curcumin did not (about 45% of inhibition at
similar concentrations [23]). The inhibitory potential of curcuminlysinate salt in cell-free system was somewhere between that of
curcumin and NDS27 (data not shown). The excipient for NDS27,
HPbCD, showed more efﬁcient inhibitory effect on the activity of
NADPH oxidase than NDS27 itself, while NDS28 and its excipient,
c-CD, had no effect suggesting that the type of cyclodextrin is
important for the mode of action of the soluble form of curcumin.
Besides an evident effect on NADPH oxidase assembly, we have
also demonstrated that NDS27 and NDS28 both act upstream in
the NADPH oxidase activation pathway by inhibiting the PKCd
activity with IC50 values of 1.67  105 M and 1.26  105 M,
respectively, these values being much lower than the curcumin
IC50 value which is about 0.6 mM [21]. Although cyclodextrins
had no direct effect on the activity of PKCd, the results obtained
by Western blot analysis showed that HPbCD and NDS27 had an
inhibitory effect on the translocation of PKCd, but not c-CD and
NDS28 suggesting a different behaviour of the soluble molecules
due to the cyclodextrin used. The difference between HPbCD and
c-CD is based on the cavity size formed by 7 or 8 dextrose units
respectively. Another structural characteristic for HPbCD is that
the hydroxyl group was esteriﬁed with a propyl group that
improved its solubility, as compared to b-cyclodextrins [29].
b-Cyclodextrins are also known to be the most effective
sterol-acceptors, due to the diameter of their internal cavity which
matches the size of these molecules [30]. With Oil Red O
colouration, we determined the ability of NDS27, NDS28 and their
respective cyclodextrins to extract the lipid content from the PMNs
cell membranes. Due to the sensitivity limitation of this technique,
the concentrations of the molecules were increased compared to
those usually used. Our results demonstrated that HPbCD and, to
a bigger extent, NDS27 were able to reduce the lipid content of
Fig. 4. Effect of NDS27 and HPbCD (A) or NDS28 and c-CD (B) on the lipid content of
PMNs measured by Oil Red O colouration and compared to control cells. The
percentages of inhibition indicated on the top of each column were calculated vs.
cells control group (Ctrl), ⁄⁄p < 0.001, ⁄p < 0.05. Data are given as means ± S.E.M
(nP 6).
Fig. 5. Example of ESR spectra obtained with 5  106 HL-60 cells incubated with 5-DSA
centrifugation, the ESR spectra were recorded on the supernatant (dotted lines) and on th
least three replicate experiments. The signal intensities of 3-lines ESR spectra, correspon
expressed in relative percentage values vs. control ones taken as 100%. Data are given a
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underlines the important role played by cyclodextrins.
To better understand the behaviour of the drugs, a set of ESR
experiments were conducted, using 5-DSA and 16-DSA probes
which have a poor solubility in water and tend to localise in the
hydrophobic parts of complex systems [31]. The main idea was
ﬁrst to investigate whether or not incubation of NDS27, or its
analog NDS28, inﬂuences the membrane ﬂuidity. Furthermore,
we also wanted to understand the mechanism of exchange
between the drugs and membrane and how it could inﬂuence
the shape and intensity of ESR signals. According to the ESR data
obtained on the HL-60 cellular model, we did not observed any
changes in membrane ﬂuidity. However, the binding of both
5- and 16-DSA at the membrane surface, indicated by ESR spectra
obtained on pellets from cells pre-incubated with the probes,
allows us to successfully demonstrate the capacity of NDS27 and
HPbCD to interact with the probes. Our ESR results are clearly in
accordance with Oil Red O experiments and indicate that NDS27
and HPbCD readily extracted probes frommembranes to the super-
natant with a better effect on the 5-DSA than the 16-DSA which is
more deeply anchored in the membrane. On the contrary, the use
of NDS28 and c-CD, led to weak ESR signals in supernatants show-
ing their low potential to extract the probes from membranes.
The latter results could be extended to the action of these
molecules on the enzymes activity. Undoubtedly, a modiﬁcation
of the lipid environment by NDS27 could be responsible for NADPH
oxidase and PKCd inhibitions. Curcumin may also play a role in this
modiﬁcation as it can bind to the membrane in a surface-
associated mode at low concentrations and a trans-membrane
mode at higher concentrations [32]. In this case, the drug is
anchored to the bilayer by a hydrogen bond near the phosphate
group of phospholipids in a manner somewhat similar to
cholesterol [32]. We have previously demonstrated that curcumin(A) or 16-DSA (B) and treated with 104 M NDS27 or 5  104 M HPbCD. After cells
e pellets (plain lines) reconstituted in HBSS. Reproducible results were obtained in at
ding to 5-DSA spectra (C) or 16-DSA spectra (D) respectively, were calculated and
s means ± S.E.M (nP 3).
Fig. 6. Example of ESR spectra obtained with 5  106 HL-60 cells incubated with 5-DSA (A) or 16-DSA (B) and treated with 104 M NDS28 or 5  104 M c-CD. After cells
centrifugation, the ESR spectra were recorded on supernatant (dotted lines) and on pellets (plain lines) reconstituted in HBSS. Reproducible results were obtained in at least
three replicate experiments. The signal intensities of 3-lines ESR spectra, corresponding to 5-DSA spectra (C) or 16-DSA spectra (D) respectively, were calculated and
expressed in relative percentage values vs. control ones taken as 100%. Data are given as means ± S.E.M (nP 3).
Fig. 7. Quantiﬁcation of curcumin from NDS27 or NDS28 (104 M) that entered or
not into PMNs after incubation. Supernatant: curcumin found in the supernatant
after 30 min incubation with cells. Wash: curcumin recovered after two washings of
the cells. Cytosol and membrane: curcumin found in cytosolic and membrane
fractions respectively after ultracentrifugation of sonicated cells. Debris: curcumin
found in granules, unbroken cells and nuclei. Data are expressed in relative
percentages vs. the sum of the amounts of curcumin found in the different fractions
taken as 100% and are given as the mean ± S.E.M of two (for NDS27) or six (for
NDS28) separate experiments (nP 2).
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remained to be tested. By HPLC analyses, we determined that cur-
cumin from NDS28 remained in great part in the extracellular
medium (85%) while 65% of curcumin from NDS27 was found
within the cells [24]. These results suggest that HPbCD easily
exchanges curcumin lysinate for lipid components while c-CD
does not, making HPbCD a better drug delivery agent for curcumin
lysinate salt. Moreover, HPbCD has been previously used in com-
plexation with other ﬂavonoids to solubilise and increase their
antioxidant capacities by protecting molecules from oxidation by
radical species [33]. Yancey et al. (1996) suggested that HPbCD is
able to diffuse into the proximity of the plasma membrane,
meaning that cholesterol molecules could enter directly into thehydrophobic pocket of the cyclodextrin without the necessity of
completely desorbing through the aqueous phase [34]. While the
suitability of b-CD and its derivatives to interact with the phospho-
lipids is questioned, the potency of b-CD to preferentially extract
cholesterol from cell membranes is broadly recognised [35].
NDS27 appeared to perform more efﬁciently in the extraction of
lipid molecules than HPbCD alone. Owing to the incorporation of
curcumin in the apolar cavity of HPbCD, a direct exchange of cur-
cumin for cholesterol could occur. On the contrary, HPbCD will ﬁrst
ﬁll its apolar cavity with water molecules that will be subsequently
exchanged for cholesterol [36]. The alteration of lipid distribution
by curcumin lysinate [37,38] and HPbCD [39] can affect the activity
of membrane proteins and the cell signalling through the
alteration of lipid raft systems (cholesterol-rich, detergent insolu-
ble compartment membranes) which participate in the signal
transduction mechanism [31]. A recent study by Tsukamoto and
co-workers [40] showed that curcumin, at very low concentration,
modulates the lipid raft domains by localising between the liquid
ordered (lo) raft and the surrounding liquid disordered (ld) phase
causing a domain fusion process. In neutrophils, FccRIIIB receptors,
associated with lipid raft by a glycophosphatidyl inositol (GPI)
anchor, are implied in the oxidase activation. Upon stimulation,
PKCd and cytosolic components of NADPH oxidase are recruited
to these microdomains and PKC phosphorylates p47phox
inducing its conformational change and its interaction with the
ﬂavocytochrome b558 [41,42]. A ﬁnal possible mechanism to
explain the inhibition of NADPH oxidase activity by the action of
curcumin on PKC (Ca2+ dependent or not) activation, is its
interaction with the Ca2+ binding domain and with a stimulatory
site located in the kinase domain of the enzyme [43].
In conclusion, our results indicate that both soluble forms of
curcumin lysinate have similar effects on the neutrophils’ MPO
and ROS scavenging activities. But, depending on the cyclodextrin
used, NDS27 and NDS28 have a totally different behaviour regard-
S. Derochette et al. / FEBS Open Bio 4 (2014) 1021–1029 1029ing NADPH oxidase and PKCd, two enzymes whose activities are
strongly linked to lipid rafts. The choice of cyclodextrin vehicle
for curcumin lysinate seems essential to preserve and improve
the capacity of the salt to interact with membranes, disturb lipid
raft domains and enter into the cytosol, and thus to disrupt the
pathways involved in the NADPH oxidase activation and the ROS
production. Our study demonstrates that NDS27, together with
HPbCD, is a better candidate than NDS28 with c-CD for the
modulation of excessive activation of PMNs. These ﬁndings may
open up therapeutic perspectives to control equine or human
pathologies with excessive inﬂammatory reactions as already
demonstrated in vivo in horses [44].
Acknowledgments
The authors thank A. Niesten and J. Romainville for their
technical assistance and M. Van Linden for reviewing the
manuscript. This work was supported by a FRIA – Belgium (Fund
for the Research in Industry and Agriculture) scholarship.
S.D., A.M.-M. and T.F. planned the experiments. The acquisition
of data was mainly performed by S.D. with precious help from
A.M.-M. and S.C. for ESR experiments. S.D., A.M.-M. and T.F.
participated for the analysis and the interpretation of data. S.D.
wrote the manuscript with the supervision and critical revision
by A.M.-M., T.F., J.C., G.D.-D. and D.S. P.N. and D.S. are the inventors
of NDS27 and P.N. is responsible for the synthesis of NDS27 and
NDS28 and the development of the HPLC method used here for
the measurement curcumin in cellular extracts.
References
[1] Dahlgren, C. and Karlsson, A. (1999) Respiratory burst in human neutrophils.
J. Immunol. Methods 232, 3–14.
[2] El-Benna, J., Dang, P.M. and Gougerot-Pocidalo, M.A. (2008) Priming of the
neutrophil NADPH oxidase activation: role of p47phox phosphorylation and
NOX2 mobilization to the plasma membrane. Semin. Immunopathol. 30, 279–
289.
[3] Selemidis, S., Sobey, C.G., Wingler, K., Schmidt, H.H.H.W. and Drummond, G.R.
(2008) NADPH oxidases in the vasculature: molecular features, roles in disease
and pharmacological inhibition. Pharmacol. Ther. 120, 254–291.
[4] Bertram, A. and Ley, K. (2011) Protein kinase C isoforms in neutrophil adhesion
and activation. Arch. Immunol. Ther. Exp. 59, 79–87.
[5] Wolfson, M., McPhail, L., Nasrallah, V. and Snyderman, R. (1985) Phorbol
myristate acetate mediates redistribution of protein kinase C in human
neutrophils: potential role in the activation of the respiratory burst enzyme. J.
Immunol. 135, 2057–2062.
[6] Kent, J.D., Sergeant, S., Burns, D.J. and McPhail, L.C. (1996) Identiﬁcation and
regulation of protein kinase C-delta in human neutrophils. J. Immunol. 157,
4641–4647.
[7] Klebanoff, S. (2005) Myeloperoxidase: friend and foe. J. Leucocyte Biol. 77,
598–625.
[8] Grulke, S., Franck, T., Gangl, M., Péters, F., Salciccia, Alexandra., Deby-Dupont,
G. and Serteyn, D. (2008) Myeloperoxidase assay in plasma and peritoneal
ﬂuid of horses with gastrointestinal disease. Can. J. Vet. Res. 72, 37–42.
[9] de la Rebière de Pouyade, G., Franck, T., Salciccia, A., Deby-Dupont, G., Grulke,
S., Heyden, L.V., Sandersen, C. and Serteyn, D. (2010) Development of an
enzyme-linked immunosorbent assay for equine neutrophil elastase
measurement in blood: preliminary application to colic cases. Vet. Immunol.
Immunopathol. 135, 282–288.
[10] R. Neviere, Sepsis and the systemic inﬂammatory response syndrome:
deﬁnitions, epidemiology, and prognosis, in: G. Finlay (Ed.), UpToDate,
Wolters Kluwer Health, 2013.
[11] Franck, T., Kohnen, S., Grulke, S., Neven, P., Goutman, Y., Péters, F., Pirotte, B.,
Deby-Dupont, G. and Serteyn, D. (2008) Inhibitory effect of curcuminoids and
tetrahydrocurcuminoids on equine activated neutrophils and
myeloperoxidase activity. Physiol. Res. 57, 577–587.
[12] Kim, J., Neupane, G., Lee, E., Jeong, B., Park, B. and Thapa, P. (2011) NADPH
oxidase inhibitors: a patent review. Expert Opin. Ther. Pat., 1744–7674.
[13] Masuda, T., Maekawa, T., Hidaka, K., Bando, H., Takeda, Y. and Yamaguchi, H.
(2001) Chemical studies on antioxidant mechanism of curcumin: analysis of
oxidative coupling products from curcumin and linoleate. J. Agric. Food Chem.
49, 2539–2547.
[14] Maheshwari, R.K., Singh, A.K., Gaddipati, J. and Srimal, R.C. (2006) Multiple
biological activities of curcumin: a short review. Life Sci. 78, 2081–2087.
[15] Deby-Dupont, G., Mouithys-Mickalad, A., Serteyn, D., Lamy, M. and Deby, C.
(2005) Resveratrol and curcumin reduce the respiratory burst of Chlamydia-
primed THP-1 cells. Biochem. Biophys. Res. Commun. 333, 21–27.[16] Kikuchi, H., Kuribayashi, F., Kiwaki, N. and Nakayama, T. (2010) Curcumin
dramatically enhance retinoic acid-induced superoxide generating activity via
accumulation of p47-phox and p67-phox proteins in U937 cells. Biochem.
Biophys. Res. Commun. 395, 61–65.
[17] Miquel, J., Bernd, A., Sempere, J.M., Diaz-Alperi, J. and Ramirez, A. (2002) The
curcuma antioxidants: pharmacological effects and prospects for future
clinical use. A review. Arch. Gerontol. Geriatr. 34, 37–46.
[18] Jurenka, J.S. (2009) Anti-inﬂammatory properties of curcumin, a major
constituent of Curcuma longa: a review of preclinical and clinical research.
Altern. Med. Rev. 14, 141–153.
[19] Reddy,R.C., Vatsalab, PalakkoduG., Keshamounia, V.G. andPadmanaban,G. (2005)
Curcumin for malaria therapy. Biochem. Biophys. Res. Commun. 326, 472–474.
[20] Shishodia, S., Sethi, G. and Aggarwal, B.B. (2005) Curcumin: getting back to the
roots. Ann. N. Y. Acad. Sci. 1056, 206–217.
[21] Reddy, S. and Aggarwal, B.B. (1994) Curcumin is a non-competitive and
selective inhibitor of phosphorylase kinase. FEBS Lett. 341, 19–22.
[22] P. Neven, D. Serteyn, J. Delarge, R. Kiss, V. Mathieu, D. Cataldo, N. Rocks, World
intellectual property organization (2009) International Publication number
WO/2009/144220 A1: Water soluble curcumin compositions for use in anti-
cancer and anti-inﬂammatory therapy. <http://www.wipo.int/patentscope/
search/en/WO2009144220>, 2009 (Accessed 13.07.2011).
[23] Derochette, S., Franck, T., Mouithys-Mickalad, A., Ceusters, J., Deby-Dupont, G.,
Lejeune, J.-P., Neven, P. and Serteyn, D. (2013) Curcumin and resveratrol act by
different ways on NADPH oxidase activity and reactive oxygen species
produced by equine neutrophils. Chem. Biol. Interact. 206, 186–193.
[24] Derochette, S., Franck, T., Mouithys-Mickalad, A., Deby-Dupont, G., Neven, P.
and Serteyn, D. (2013) Intra- and extracellular antioxidant capacities of the
new water-soluble form of curcumin (NDS27) on stimulated neutrophils and
HL-60 cells. Chem. Biol. Interact. 201, 49–57.
[25] Paclet, M.-H., Beryhier, S., Kuhn, L., Garin, J. and Morel, F. (2006) Regulation of
phagocyte NADPH oxidase activity: identiﬁcation of two cytochrome b558
activation states. FASEB J. 21, 1244–1255.
[26] Abramoff, M.D., Magalhaes, P.J. and Ram, S.J. (2004) Image Processing with
ImageJ. Biophotonics Int. 11, 36–42.
[27] Nakamura, Y., Ohto, Y., Murakami, A., Osawa, T. and Ohigashi, H. (1998)
Inhibitory effects of curcumin and tetrahydrocurcuminoids on the tumor
promoter-induced reactive oxygen species generation in leukocytes in vitro
and in vivo. Cancer Sci. 89, 361–370.
[28] Yadav, V.R., Prasad, S., Kannappan, R., Ravindran, J., Chaturvedi, M.M., Vaahtera,
L., Parkkinen, J. and Aggarwal, B.B. (2010) Cyclodextrin-complexed curcumin
exhibits anti-inﬂammatory and antiproliferative activities superior to those of
curcumin through higher cellular uptake. Biochem. Pharmacol. 80, 1021–1032.
[29] Davis, M.E. and Brewster, M.E. (2004) Cyclodextrin-based pharmaceutics:
past, present and future. Nat. Rev. Drug Discov. 3, 1023–1035.
[30] López, C.A., de Vries, A.H. and Marrink, S.J. (2011) Molecular mechanism of
cyclodextrin mediated cholesterol extraction. PLoS Comput. Biol. 7, e1002020.
[31] Grammenos, A., Mouithys-Mickalad, A., Guelluy, P.H., Lismont, M., Piel, G. and
Hoebeke,M. (2010) ESR technique for noninvasiveway to quantify cyclodextrins
effect on cell membranes. Biochem. Biophys. Res. Commun. 398, 350–354.
[32] Barry, J., Fritz, M., Brender, J.R., Smith, P.E.S., Lee, D.-K. and Ramamoorthy, A.
(2009) Determining the effects of lipophilic drugs on membrane structure by
solid-state NMR spectroscopy: the case of the antioxidant curcumin. J. Am.
Chem. Soc. 131, 4490–4498.
[33] Mercader-Ros, M.T., Lucas-Abellán, C., Fortea, M.I., Gabaldón, J.A. and Núñez-
Delicado, E. (2010) Effect of HP-b-cyclodextrins complexation on the
antioxidant activity of ﬂavonols. Food Chem. 118, 769–773.
[34] Yancey, P.G., Rodrigueza, W.V., Kilsdonk, E.P., Stoudt, G.W., Johnson, W.J.,
Phillips, M.C. and Rothblat, G.H. (1996) Cellular cholesterol efﬂux mediated by
cyclodextrins. Demonstration of kinetic pools and mechanism of efﬂux. J. Biol.
Chem. 271, 16026–16034.
[35] Castagne, D., Evrard, B., Nusgens, B. and Piel, R. (2010) Effect of beta-
cyclodextrin and its derivatives on caveolae disruption, relationships with
their cholesterol extraction capacities. J. Incl. Phenom. Macrocycl. Chem. 67, 8.
[36] Del Valle, E.M.M. (2004) Cyclodextrins and their uses: a review. Process
Biochem. 39, 1033–1046.
[37] Hung, W.-C., Chen, F.-Y., Lee, C.-C., Sun, Y., Lee, M.-T. and Huang, H.W. (2008)
Membrane-thinning effect of curcumin. Biophys. J. 94, 4331–4338.
[38] Ingolfsson, H.I., Koeppe, R.E. and Andersen, O.S. (2007) Curcumin is a
modulator of bilayer material properties. Biochemistry 46, 10384–10391.
[39] Christian, A.E., Haynes, M.P., Phillips, M.C. and Rothblat, G.H. (1997) Use of
cyclodextrins for manipulating cellular cholesterol content. J. Lipid Res. 38,
2264–2272.
[40] Tsukamoto, M., Kuroda, K., Ramamoorthy, A. and Yasuhara, K. (2014)
Modulation of raft domains in a lipid bilayer by boundary-active curcumin.
Chem. Commun. 50, 3427–3430.
[41] Shao, D., Segal, A.W. and Dekker, L.V. (2003) Lipid rafts determine efﬁciency of
NADPH oxidase activation in neutrophils. FEBS Lett. 550, 101–106.
[42] Vilhardt, F. and van Deurs, B. (2004) The phagocyte NADPH oxidase depends
on cholesterol-enriched membrane microdomains for assembly. Eur. Mol.
Biol. Organ. J. 23, 739–748.
[43] Mahmmoud, Y.A. (2007) Modulation of protein kinase C by curcumin;
inhibition and activation switched by calcium ions. Br. J. Pharmacol. 150,
200–208.
[44] Sandersen, C., Oleynik, D., Franck, T., Neven, P., Serteyn, D. and Art, T. (2011)
Inhalation with NDS27 attenuates pulmonary neutrophilic inﬂammation in
recurrent airway obstruction. Vet. Rec., 1–2.
